Dimensional Fund Advisors LP Has $32.17 Million Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Dimensional Fund Advisors LP lifted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 17.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,379,715 shares of the company's stock after acquiring an additional 505,180 shares during the period. Dimensional Fund Advisors LP owned approximately 2.51% of AdaptHealth worth $32,174,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Barclays PLC boosted its stake in AdaptHealth by 361.3% in the 3rd quarter. Barclays PLC now owns 181,240 shares of the company's stock worth $2,034,000 after purchasing an additional 141,949 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of AdaptHealth by 73.2% in the third quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company's stock valued at $2,154,000 after purchasing an additional 81,097 shares in the last quarter. Reinhart Partners LLC. boosted its position in shares of AdaptHealth by 1.1% during the fourth quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company's stock worth $59,660,000 after buying an additional 68,212 shares during the period. Proficio Capital Partners LLC bought a new position in shares of AdaptHealth during the fourth quarter worth about $181,000. Finally, Pacer Advisors Inc. acquired a new stake in AdaptHealth in the 4th quarter valued at approximately $76,271,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Stock Up 2.3%

Shares of NASDAQ AHCO traded up $0.19 during trading hours on Friday, hitting $8.57. The company had a trading volume of 942,001 shares, compared to its average volume of 1,275,093. AdaptHealth Corp. has a 1-year low of $7.11 and a 1-year high of $11.90. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The firm's 50 day moving average is $9.29 and its 200-day moving average is $9.73. The stock has a market capitalization of $1.16 billion, a P/E ratio of -5.19, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64.

Analysts Set New Price Targets

A number of research firms have weighed in on AHCO. UBS Group reduced their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Canaccord Genuity Group increased their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Truist Financial raised their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday. Finally, Robert W. Baird increased their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $13.60.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.